effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast...
effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort
About this item
Full title
Author / Creator
Publisher
Boston: Boston : Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Boston : Springer US
Subjects
More information
Scope and Contents
Contents
The use of clinicopathologic features in decision-making in early stage estrogen receptor (ER)-positive breast cancer (BC) may lead to over or under treatment. We investigated the effect of the Oncotype Dx® (ODX) on chemotherapy (CTX) utilization in two cancer centers. 276 cases of node-negative ER-positive BC had ODX between 2005 and 2009. Age at...
Alternative Titles
Full title
effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_857483137
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_857483137
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-010-1329-6
